Boston Pharmaceuticals Receives $600,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c9c69a80-486e-4e16-bb6d-6dca7201b254
Date
11/20/2015
Company Name
Boston Pharmaceuticals
Mailing Address
Undisclosed Cambridge, MA 02138 USA
Company Description
This is a new way to develop and to bring to market innovative medicines. We believe that the combination of our dedicated capital pool and extensive industry expertise will give Boston Pharmaceuticals a significant competitive advantage in this space.
Website
Undisclosed
Transaction Type
Venture Equity
Transaction Amount
$600,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Boston Pharmaceuticals is a fully-integrated drug development company that will offer an innovative alternative model for drug development and commercialization.
M&A Terms
Venture Investor
Gurnet Point Capital
Venture Investor
Investor